Click Here for 5% Off Your First Aladdin Purchase!

eliapixant , CAS No.1948229-21-7, Antagonist of P2X3

  • Moligand™
Item Number
E610099
Grouped product items
SKUSizeAvailabilityPrice Qty
E610099-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$240.90
E610099-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$830.90
View related series
P2X3 Antagonist

Basic Description

SynonymsEliapixant|Eliapixant [INN]|Eliapixant [USAN]|1948229-21-7|9GH7E6347B|Eliapixant [USAN:INN]|BAY1817080|BAY 1817080|BAY-1817080|UNII-9GH7E6347B|WHO 11269|3-(5-methyl-1,3-thiazol-2-yl)-5-[(3R)-oxolan-3-yl]oxy-N-[(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]eth
GradeMoligand™
Action TypeANTAGONIST
Mechanism of actionAntagonist of P2X3

Associated Targets

P2RX3 Tclin P2X purinoceptor 3 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name 3-(5-methyl-1,3-thiazol-2-yl)-5-[(3R)-oxolan-3-yl]oxy-N-[(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl]benzamide
INCHI InChI=1S/C22H21F3N4O3S/c1-12-8-26-20(33-12)15-5-14(6-18(7-15)32-17-3-4-31-11-17)19(30)29-13(2)16-9-27-21(28-10-16)22(23,24)25/h5-10,13,17H,3-4,11H2,1-2H3,(H,29,30)/t13-,17-/m1/s1
InChi Key GTQPEQGDLVSFJO-CXAGYDPISA-N
Canonical SMILES Cc1cnc(s1)c1cc(cc(c1)O[C@@H]1CCOC1)C(=O)N[C@H](C)c1cnc(nc1)C(F)(F)F
Isomeric SMILES CC1=CN=C(S1)C2=CC(=CC(=C2)O[C@@H]3CCOC3)C(=O)N[C@H](C)C4=CN=C(N=C4)C(F)(F)F
PubChem CID 121397587

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Related Documents

References

1. Morice A, Smith JA, McGarvey L, Birring SS, Parker SM, Turner A, Hummel T, Gashaw I, Fels L, Klein S et al..  (2021)  Eliapixant (BAY 1817080), a P2X3 receptor antagonist, in refractory chronic cough: a randomised, placebo-controlled, crossover phase 2a study..  Eur Respir J,  58  (5): (2004240).  [PMID:33986030]
2. Davenport AJ, Neagoe I, Bräuer N, Koch M, Rotgeri A, Nagel J, Laux-Biehlmann A, Machet F, Coelho AM, Boyce S et al..  (2021)  Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibers..  Sci Rep,  11  (1): (19877).  [PMID:34615939]

Solution Calculators